MMRF Research Roundtables encourage the sharing of ideas and knowledge, and build a team approach to finding a cure in cutting-edge areas of research. MMRF Roundtables bring together world leaders in academic research, the NCI, and the pharmaceutical industry. MMRF Roundtables are closed door, invite only (limited to 25 participants), interactive sessions whereby everyone in attendance presents their unpublished work. Meeting abstract books are disseminated to participants and a meeting summary may be submitted to peer-reviewed journals.

Read Development of Effective New Treatments for Myeloma, the resulting publication from the February 2004 Roundtable featured in the Journal of Clinical Oncology.

• January 29-30 - Tampa, FL
Combination Strategies in the Treatment of Multiple Myeloma Research Roundtable

• November 21-22 - New York, NY
Validating Compounds for Multiple Myeloma
• June 15-16 - Washington, DC
A Strategic Framework for Novel Drug Development in Multiple Myeloma
• February 1 - New York, NY
Therapeutic Targets Research Roundtable

• September 27-28 - New York, NY
Establishing a Framework for Conducting Intergroup Clinical Trials in Myeloma
• April 20-21 - Torino, Italy
Novel Targeted Therapies for the Treatment of Multiple Myeloma
• February 24-25 - Washington, DC
Novel Targeted Therapies for the Treatment of Multiple Myeloma

• May 21-22 - Salamanca, Spain
Novel Targeted Therapeutics for the Treatment of Multiple Myeloma
• February 20-23 - Paris, France
Molecular Genetics of Multiple Myeloma

• October 4-5 - New York, NY
The Development of Novel Targeted Therapeutics for the Treatment of Multiple Myeloma
• March 17-18 - New York, NY
Advances in Plasma Cell Formation and Tumorigenesis Roundtable